Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo et al.
Ann Rheum Dis
; 81(11): e223, 2022 11.
Article
in English
| MEDLINE | ID: covidwho-2113807
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Physicians
/
Rheumatology
/
Rheumatic Diseases
/
Musculoskeletal Diseases
/
COVID-19
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Ann Rheum Dis
Year:
2022
Document Type:
Article
Affiliation country:
Annrheumdis-2020-218910
Similar
MEDLINE
...
LILACS
LIS